“Comparison Of The Efficacy And Safety Of Secukinumab, Ustekinumab And Guselkumab For The Treatment Of Moderate To Severe Plaque Psoriasis: A Systematic Review”, Journal of Pharmaceutical Negative Results, pp. 485–495, Jan. 2023, doi: 10.47750/pnr.2023.14.02.62.